Wearable maker Whoop raised $575M led by Collaborative Fund at a $10.1B valuation and says it hit $1B in ARR by 2025's end; 60% of its 2025 sales were non-US
With elite athletes like LeBron James and Cristiano Ronaldo as investors, the company, now valued at $10 billion, is courting everyday health enthusiasts.
New York TimesNiko Gallogly
Context & Ripple Effects
Whoop has progressed from an athlete-performance tracker through repeated financing rounds, including its 2021 backing for a subscription-based health-coaching model. Its latest fundraise and reported recurring-revenue scale show that model has become central rather than ancillary.
Whoop gains $575M to fund expansion while its $10.1B valuation sets a much higher benchmark for execution against its reported $1B ARR.
A customer base led increasingly by everyday health users and international buyers becomes more important to growth than the company’s original athlete-focused constituency.
Second-order effects
Other subscription wearable vendors face more pressure to pair hardware with ongoing coaching or health insights, rather than compete on device sales alone.
Whoop can direct more resources toward international distribution, localization, and customer acquisition; sustaining the stated sales mix will test whether recurring engagement travels across markets.
Third-order effects
If this model holds, wearables may be valued less as low-margin gadgets and more as recurring-revenue health-service platforms, with retention and data-derived features becoming the key competitive assets.
The move toward medical-grade positioning could sharpen the industry divide between general fitness tracking and products expected to substantiate health-oriented claims.
The trend: Consumer wearables are converging on subscription-led, health-focused platforms that use specialized hardware as the entry point for recurring services.
Congrats to @willahmed, @ed_baker_whoop, @Durkin and the entire team at @whoop on their latest round. They are on their way to building the best/ most accessible consumer health company in the world.
Congrats @willahmed and the @whoop team. It's been amazing to witness this company's progress from humble beginnings. More than most companies of such scale, it truly always feels like day 1 at Whoop. Very excited for the journey ahead as you push further into preventative
We've been building toward this moment for over a decade. $575M raised. $10.1B valuation. 2.5M+ members worldwide and growing. Backed by leaders in health, performance, and global sport. We're scaling a new standard for personalized, preventive health. And we're just getting
If you want to join us, we are hiring for 600 roles at Whoop across every function. I am highly skeptical that AI is going to replace all labor forever and we are investing heavily in our team and our tools to grow careers at Whoop. https://www.whoop.com/careers
BREAKING: WHOOP RAISES $575M AT $10.1B VALUATION I am pleased to announce that we've raised $575M at a $10.1B valuation to accelerate our mission of unlocking human performance and healthspan globally. This round was led by Collaborative Fund with participation from 2PointZero [i…
Requirement for FDA clearance on something of these things is bullshit given that you can claim all sorts of ridiculous things in supplements, as long as you have a disclaimer that it isn't approved to do any of the things claimed.